Overexpression of ACE2 in patients with underlying cardiovascular disease may therefore result in severe respiratory symptoms in patients with underlying cardiovascular diseases such as hypertension, cerebrovascular disease or diabetes [39]. This evidence concerns the gene ACE2 and cerebrovascular disorder.